01/11/2026
Great work Children's Hospital of Philadelphia!!! Thank you!
American institute developed artificial womb sustaining premature babies outside mothers successfully. Researchers at the Children's Hospital of Philadelphia created a bio-bag that mimics the uterine environment, successfully sustaining extremely premature lambs for four weeks with normal development. The technology offers revolutionary treatment for babies born months early, when survival rates and lifelong complications are highest.
Babies born before 28 weeks face mortality rates above 50% and survivors often suffer lifelong disabilities—cerebral palsy, blindness, chronic lung disease, developmental delays. Current incubators expose fragile lungs to air and require mechanical ventilation that causes damage. The artificial womb provides a sealed, fluid-filled environment with umbilical connections providing oxygen and nutrients just like inside the mother.
The bio-bag is a transparent plastic enclosure filled with synthetic amniotic fluid maintained at body temperature. The premature baby floats inside, connected to a machine that oxygenates blood through the umbilical cord while removing carbon dioxide. No breathing required, no lung stress—the baby continues development as if still in utero. Sensors monitor vital signs continuously. The fluid-filled environment protects developing organs from temperature fluctuations and infection.
Lamb trials achieved 100% survival with normal organ development. Human trials are beginning in 2026 with babies born at 22-24 weeks—the edge of viability. Success could save 30,000 American babies annually who die from extreme prematurity. We're extending the boundary of viable birth earlier, giving the most vulnerable infants time to develop before facing the outside world.
Source: Children's Hospital of Philadelphia, Nature Communications 2025